DAYONG ZHOU

Dr. DAYONG ZHOU

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2024 in Plants
Verified
Journal Article
Open access
PDF file
RZRuiqin Zhong
Ruiqin Zhong
DZDAYONG ZHOU
DAYONG ZHOU
LCLirong Chen
Lirong Chen
JRJohn P. Rose
John P. Rose
BWBi-cheng Wang
Bi-cheng Wang
ZYZheng-Hua Ye
Zheng-Hua Ye
Plant cell walls are largely composed of polysaccharide polymers, including cellulose, hemicelluloses (xyloglucan, xylan, mannan, and mixed-linkage β-1,3/1,4-glucan), and pectins. Among these cell wall polysaccharides, xyloglucan, xylan, mannan, and pectins are often O-acetylated, and polysaccharide O-acetylation plays important roles in cell wall assembly and disease resistance. Genetic and biochemical analyses have implicated the involvement of three groups of proteins in plant cell wall polysaccharide O-acetylation: trichome birefringence-like (TBL)/domain of unknown function 231 (DUF231), reduced wall acetylation (RWA), and altered xyloglucan 9 (AXY9). Although the exact roles of RWAs and AXY9 are yet to be identified, members of the TBL/DUF231 family have been found to be O-acetyltransferases responsible for the O-acetylation of xyloglucan, xylan, mannan, and pectins. Here, we provide a comprehensive overview of the occurrence of O-acetylated cell wall polysaccharides, the biochemical properties, structural features, and evolution of cell wall polysaccharide O-acetyltransferases, and the potential biotechnological applications of manipulations of cell wall polysaccharide acetylation. Further in-depth studies of the biochemical mechanisms of cell wall polysaccharide O-acetylation will not only enrich our understanding of cell wall biology, but also have important implications in engineering plants with increased disease resistance and reduced recalcitrance for biofuel production.

26 September 2025 in Plant and Cell Physiology
Verified
Journal Article
Closed access
RZRuiqin Zhong
Ruiqin Zhong
DZDAYONG ZHOU
DAYONG ZHOU
DPDennis R Phillips
Dennis R Phillips
EAEarle R Adams
Earle R Adams
BWBi-Cheng Wang
Bi-Cheng Wang
ZYZheng-Hua Ye
Zheng-Hua Ye
Plant cell wall polysaccharide glycosyltransferases catalyze the transfer of sugars from specific nucleotide sugar donors onto specific acceptor substrates. The mechanisms of how their enzymatic specificity is determined are one of the long-standing questions in plant cell wall biology. In this report, we studied the biochemical functions of Arabidopsis and poplar GT61 glycosyltransferases involved in xylan substitutions and investigated the molecular determinants of their nucleotide sugar donor specificity. Enzymatic activity assays of recombinant proteins of Arabidopsis and poplar GT61 members demonstrated that two of them, AtX2AT1 and PtrX2AT1, exhibited xylan 2-O-arabinosyltransferase activities specifically using UDP-Araf, two other ones, AtXYXT2/3, possessed xylan 2-O-xylosyltransferase activities specifically using UDP-Xyl, and three other ones, PtrXXAT1/2/3, were able to catalyze the transfer of 2-O-Araf and 2-O-Xyl onto xylan using both UDP-Araf and UDP-Xyl. Structural modeling and molecular docking of PtrXXAT1 identified amino acid residues involved in interacting with UDP-Araf and UDP-Xyl at the putative active site and site-directed mutagenesis revealed their critical roles in PtrXXAT1 catalytic activities. Furthermore, structural alignment and reciprocal swapping of UDP-Xyl-interacting residues of PtrXXAT1 with their corresponding residues of AtX2AT1 pinpointed key residues determining their nucleotide sugar donor specificity. Our results indicate that Arabidopsis and poplar GT61 members catalyze 2-O-Araf- and/or 2-O-Xyl substitutions of xylan and that subtle structural differences in their substrate-binding pockets could alter their substrate specificity toward nucleotide sugar donors.

1 April 2026 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Open access
PDF file
DZDAYONG ZHOU
DAYONG ZHOU
LCLirong Chen
Lirong Chen
JRJohn P. Rose
John P. Rose
BWBi-cheng Wang
Bi-cheng Wang
Recently, there has been growing interest in the function and physiological importance of human TANGO2 (transport and Golgi organization 2 homolog), particularly whether it acts as a heme-trafficking protein. To address this question, we experimentally determined the three-dimensional structure of TANGO2. Our crystallographic analysis indicates that interactions between heme and TANGO2 are nonspecific. Structural comparison of the TANGO2 crystal structure with known cysteine Ntn-hydrolases allowed us to identify a putative active site, catalytic residues and a substrate-binding cavity that correspond to residues that are mutated in pathogenic TANGO2 variants. Based on these features, we propose that TANGO2 may utilize fatty-acid derivatives as substrates, suggesting a potential role in lipid metabolism. Mutations in the human TANGO2 gene cause TANGO2 deficiency disorder, a multisystem, life-threatening disease with onset in early childhood. Together, our results provide new insights into the molecular function of TANGO2 and help to resolve the ongoing debate regarding whether it functions as a heme-trafficking protein.

1 March 2020 in Journal of Biomaterials and Tissue Engineering
Verified
Journal Article
Closed access
YTYao Tang
Yao Tang
JHJian Huang
Jian Huang
LSLiming Shen
Liming Shen
ZLZhanAo Liu
ZhanAo Liu
DZDAYONG ZHOU
DAYONG ZHOU
Objective: To assess cilostazol’s effect on rats with diabetic lower limb ischemia. Methods: 36 Sprague-Dawley rats were randomly separated into normal group (n = 12), model group (n = 12) and cilostazol group (n = 12). The model of diabetic lower limb ischemia was prepared and normal saline was intraperitoneally injected postoperatively into model group. Besides, cilostazol was administrated through intraperitoneal injection after establishment of model in cilostazol group. After intervention for 6 weeks, doppler blood flow imager was employed to detect blood flow, and the expressions of MMP-8 and MMP-9 were assessed via immunohistochemistry, western blotting or quantitative polymerase chain reaction (qPCR). TUNEL assay was performed to evaluate cell apop-tosis. Results: Doppler blood flow imager showed that compared with normal group, perfusion unit (PU) index was significantly reduced in the other two groups (P < 0.05) with higher value in cilosta-zol group (P < 0.05). The immunohistochemistry results revealed that in comparison with those in normal group, MMP-8 and MMP-9 positive staining was significantly elevated in the other two groups (P < 0.05) with higher level in cilostazol group than model group. In addition, MMP-8 and MMP-9 expressions were significantly elevated in other two groups (P < 0.05), with higher level in cilostazol group (P < 0.05). Moreover, the vascular wall smooth muscle cells in the other two groups had a significantly elevated apoptosis rate (P < 0.05) with higher apoptosis in cilostazol group (P < 0.05). Conclusion: Cilostazol up-regulates MMP-8 and MMP-9 to increase the apoptosis of vascular wall smooth muscle cells, thereby improving the blood flow in rats with diabetic lower limb ischemia.